Go Pro
CVE:IGX

IntelGenx Technologies (IGX) Stock Price, News & Analysis

IntelGenx Technologies logo
C$0.58 +0.01 (+1.75%)
As of 10/6/2021

About IntelGenx Technologies Stock (CVE:IGX)

Key Stats

Today's Range
C$0.58
C$0.60
50-Day Range
C$0.58
C$0.58
52-Week Range
C$0.17
C$0.85
Volume
11,848 shs
Average Volume
56,279 shs
Market Capitalization
C$87.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine. The company's products under development comprise INT0004/2006, an antidepressant; INT0046/2018 for adult use; INT0007/2006 for the treatment of erectile dysfunction; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat opioid addition; INT0036/2013 for schizophrenia; and INT0043/2015 to treat Alzheimer's disease; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0040/2014, INT0052/2020, and INT0053/2020. The company has licensing, development, and supply agreement with Tilray, Inc. and Gensco Pharma; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.

Receive IGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IntelGenx Technologies and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IGX Stock News Headlines

IntelGenx Technologies Corp.
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel
IntelGenx: Q1 Earnings Snapshot
Stocks in play: IntelGenx Corp.
See More Headlines

IGX Stock Analysis - Frequently Asked Questions

IntelGenx Technologies' stock was trading at C$0.58 at the start of the year. Since then, IGX stock has increased by 0.0% and is now trading at C$0.58.

Shares of IGX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that IntelGenx Technologies investors own include IntelGenx Technologies (IGXT), Trican Well Service (TCW), Aurora Cannabis (ACB), New Age Brands (NF), AutoZone (AZO) and Bonterra Energy (BNE).

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
CVE:IGX
CIK
N/A
Fax
N/A
Employees
2,050
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
164.62
Current Ratio
2.77
Quick Ratio
2.69

Sales & Book Value

Annual Sales
C$1.75 million
Price / Sales
49.95
Cash Flow
C$0.08 per share
Price / Cash Flow
7.16
Book Value
C$0.05 per share
Price / Book
12.89

Miscellaneous

Outstanding Shares
150,546,000
Free Float
N/A
Market Cap
C$87.32 million
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (CVE:IGX) was last updated on 8/11/2026 by MarketBeat.com Staff.
From Our Partners